[1]
|
Bataller, R. and Brenner, D.A. (2005) Liver fibrosis. Journal of Clinical Investigation, 115, 209-218.
|
[2]
|
Friedman, S.L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-1669.
doi:10.1053/j.gastro.2008.03.003
|
[3]
|
Gressner, A.M. and Weiskirchen, R. (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular and Molecular Medicine, 10, 76-99. doi:10.1111/j.1582-4934.2006.tb00292.x
|
[4]
|
Dranoff, J.A. and Wells, R.G. (2010) Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology, 51, 1438-1444. doi:10.1002/hep.23405
|
[5]
|
Tomur, A., Kanter, M., Gurel, A. and Erboga, M. (2011) The efficiency of CAPE on retardation of hepatic fibrosis in biliary obstructed rats. Journal of Molecular Histology, 42, 451-458. doi:10.1007/s10735-011-9350-6
|
[6]
|
Matsuzaki, K., Murata, M., Yoshida, K., Sekimoto, G., Uemura, Y., Sakaida, N., et al. (2007) Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology, 46, 48-57. doi:10.1002/hep.21672
|
[7]
|
Miranda-Díaz, A.G., Hermosillo-Sandoval, J.M., LópezGuillén, G.G., Cardona-Munoz, E.G., García-Iglesias, T., Pacheco-Moisés, F., et al. (2010) Tumor necrosis factor and Interleukin-6 levels among patients suffering a bile duct injury during cholecystectomy. Revista Médica de Chile, 138, 1259-1263.
|
[8]
|
Miranda-Díaz, A.G., Hermosillo-Sandoval, J.M., Ortiz, G.G., Lizardi-García, D., Cardona-Munoz, E.G., Pacheco-Moisés, F. (2010) Serum oxidative stress is increased in patients with post cholecystectomy bile duct injury. Revista Espanola de Enfermedades Digestivas, 102, 352-356. doi:10.4321/S1130-01082010000600002
|
[9]
|
Forbes, S.J. and Parola, M. (2011) Liver fibrogenic cells. Best Practice & Research Clinical Gastroenterology, 25, 207-217. doi:10.1016/j.bpg.2011.02.006
|
[10]
|
Kalluri, R. and Neilson, E.G. (2003) Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation, 112, 1776-1784.
|
[11]
|
Larghi, A., Tringali, A., Lecca, P.G., Giordano, M. and Costamagna, G. (2008) Management of hilar biliary strictures. The American Journal of Gastroenterology, 103, 458-473. doi:10.1111/j.1572-0241.2007.01645.x
|
[12]
|
Pesce, A., Portale, T.R., Minutolo, V., Scilletta, R., Li Destri, G. and Puleo, S. (2012) Bile duct injury during laparoscopic cholecystectomy without intraoperative cholangiography: A retrospective study on 1100 selected patients. Digestive Surgery, 13, 310-314.
doi:10.1159/000341660
|
[13]
|
Takeda, K., Kojima, Y., Ikejima, K., Harada, K., Yamashina, S., Okumura, K., et al. (2008) Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proceedings of the National Academy of Sciences of USA, 105, 10895-10900. doi:10.1073/pnas.0802702105
|
[14]
|
Tornqvist, B., Zheng, Z., Ye, W., Waage, A., Nilsson, M. (2009) Long-term effects of iatrogenic bile duct injury during cholecystectomy. Clin Gastroenterol Hepatol, 7, 1013-1018. doi:10.1016/j.cgh.2009.05.014
|
[15]
|
Tornqvist, B., Stromberg, C., Persson, G. and Nilsson, M. (2012) Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: Population based cohort study. BMJ, 345, Article ID: e6457. doi:10.1136/bmj.e6457
|
[16]
|
Hammel, P., Couvelard, A., O’Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J., F., Degott, C., et al. (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. The New England Journal of Medicine, 344, 418-423. doi:10.1056/NEJM200102083440604
|
[17]
|
Kisseleva, T. and Brenner, D.A. (2011) Anti-fibrogenic strategies and the regression of fibrosis. Best Practice & Research Clinical Gastroenterology, 25, 305-317.
doi:10.1016/j.bpg.2011.02.011
|
[18]
|
Tsalis, K.G., Christoforidis, E.C., Dimitriadis, C.A., Kalfadis, S.C., Botsios, D.S. and Dadoukis, J.D. (2003) Management of bile duct injury during and after laparoscopic cholecystectomy. Surgical Endoscopy, 17, 31-37.
doi:10.1007/s00464-001-9230-3
|
[19]
|
Strasberg, S.M., Hertl, M. and Soper, N.J. (1995) An analysis of the problem of biliary injury during laparoscopic cholecystectomy. Journal of the American College of Surgeons, 180, 101-125.
|
[20]
|
Pausawasadi, N., Soontornmanokul, T. and Rerknimitr, R. (2012) Role of fully covered self-expandable metal stent for treatment of benign biliary strictures and bile leaks. Korean Journal of Radiology, 13, S67-S73.
doi:10.3348/kjr.2012.13.S1.S67
|
[21]
|
Barauskas, G., Paskauskas, S., Dambrauskas, Z., Gulbinas, A. and Pundzius, J. (2012) Referral pattern, management, and long-term results of laparoscopic bile duct injuries: A case series of 44 patients. Medicina, 48, 138-144.
|
[22]
|
Smyk, D., Cholongitas, E., Kriese, S., Rigopoulou, E.I. and Bogdanos, D.P. (2011) Primary biliary cirrhosis: Family stories. Autoimmune Diseases, 2011, Article ID: 189585. doi:10.4061/2011/189585
|
[23]
|
Smyk, D., Rigopoulou, E.I., Zen, Y., Abeles, R.D., Billinis, C., Pares, A., et al. (2012) Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? World Journal of Gastroenterology, 18, 4855-4865.
doi:10.3748/wjg.v18.i35.4855
|
[24]
|
Deng, B.C., Lv, S., Cui, W., Zhao, R., Lu, X., Wu, J. and Liu, P. (2012) Novel ATP8B1 mutation in an adult male with progressive familial intrahepatic cholestasis. World Journal of Gastroenterology, 18, 6504-6509.
doi:10.3748/wjg.v18.i44.6504
|
[25]
|
Hartley, J.L., Davenport, M. and Kelly, D.A. (2009) Biliary atresia. Lancet, 374, 1704-1713.
doi:10.1016/S0140-6736(09)60946-6
|
[26]
|
Hsiao, C.H., Chang, M.H., Chen, H.L., Lee, H.C., Wu, T.C., Lin, C.C., et al. (2008) Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology, 47, 1233-1240. doi:10.1002/hep.22182
|
[27]
|
Basset, M.D. and Murray, K.F. (2008) Biliary atresia. Recent progress. Journal of Clinical Gastroenterology, 42, 720-729. doi:10.1097/MCG.0b013e3181646730
|
[28]
|
Muraji, T., Suskind, D.L. and Irie, N. (2009) Biliary atresia: A new immunological insight into etiopathogenesis. Expert Review of Gastroenterology & Hepatology, 3, 599-606. doi:10.1586/egh.09.61
|
[29]
|
Allen, S.R., Jafri, M., Donnelly, B., McNeal, M., Witte, D., Bezerra. J. et al. (2007) Effect of rotavirus strains on the murine model of biliary atresia. Journal of Virology, 81, 1671-1679. doi:10.1128/JVI.02094-06
|
[30]
|
Rauschenfels, S., Krassmann, M., Al-Masri, A.N., Verhagen, W., Leonhardt, J., Kuebler, J. F., et al. (2009) Incidence of hepatotropic viruses in biliary atresia. European Journal of Pediatrics, 168, 469-476.
doi:10.1007/s00431-008-0774-2
|
[31]
|
Narayanaswamy, B., Gonde, C., Tredger, J.M., Hussain, M., Vergani, D. and Davenport, M. (2007) Serial circulating markers of inflammation in biliary atresia—Evolution of the post-operative inflammatory process. Hepatology, 46, 180-187. doi:10.1002/hep.21701
|
[32]
|
Pakarinen, M.P. and Rintala, R.J. (2011) Surgery of biliary atresia. Scandinavian Journal of Surgery, 100, 49-53.
|
[33]
|
Roquete, M.L., Ferreira, A.R., Fagundes, E.D., Castro, L.P., Silva, R.A. and Penna, F.J. (2008) Accuracy of echogenic portal enlargement image on ultrasonographic exams and histopathology in differential diagnosis of biliary atresia. Journal of Pediatrics, 84, 331-336.
doi:10.2223/JPED.1811
|
[34]
|
Fernandez, M., Mejias, M., Garcia-Pras, E., Mendez, R., Garcia-Pagan, J.C. and Bosch, J. (2007) Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology, 46, 1208-1217. doi:10.1002/hep.21785
|
[35]
|
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D.J., et al. (2003) Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut, 52, 1347-1354.
doi:10.1136/gut.52.9.1347
|
[36]
|
Kim, M.Y. and Baik, S.K. (2009) Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension. Korean Journal of Gastroenterology, 54, 143-148.
doi:10.4166/kjg.2009.54.3.143
|
[37]
|
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., et al. (2001) Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology, 34, 745-750.
doi:10.1053/jhep.2001.28231
|
[38]
|
Xing, T., Li, L., Cao, H. and Huang, J. (2007) Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clinical & Experimental Immunology, 147, 184-188.
|
[39]
|
Ling, H., Roux, E., Hempel, D., Tao, J., Smith, M., Lonning, S., Zuk, A., Arbeeny, C. and Ledbetter, S. (2013) Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats. PLoS One, 8, Article ID: e54499. doi:10.1371/journal.pone.0054499
|
[40]
|
Wang, B., Li, W., Chen, Y., Wang, Y., Sun, C., Chen, Y., Lu, H., Fan, J. and Li, D. (2012) Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis. Medical Science Monitor, 18, 394-401.
doi:10.12659/MSM.883479
|
[41]
|
del Pilar, Alatorre-Carranza, M., Miranda-Díaz, A., YanezSánchez, I., Pizano-Martínez, O., Hermosillo-Sandoval, J.M., Vázquez-Del Mercado, M., et al. (2009) Liver fibrosis secondary to bile duct injury: Correlation of Smad7 with TGF-beta and extracellular matrix proteins. BMC Gastroenterology, 9, 81.
doi:10.1186/1471-230X-9-81
|
[42]
|
Sun, C.K., Chen, C.H., Kao, Y.H., Yuen, C.M., Sheu, J.J., Lee, F.Y., et al. (2011) Bone marrow cells reduce fibrogenesis and enhance regeneration in fibrotic rat liver. Journal of Surgical Research, 169, e15-e26.
doi:10.1016/j.jss.2010.03.023
|
[43]
|
Takami, T., Terai, S. and Sakaida, I. (2011) Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients. Journal of Pharmacological Sciences, 115, 274-278.
doi:10.1254/jphs.10R13FM
|
[44]
|
Yoshiji, H., Noguchi, R., Ikenaka, Y., Namisaki, T., Kitade, M., Kaji, K., et al. (2009) Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat. BMC Research Notes, 2, 70. doi:10.1186/1756-0500-2-70
|
[45]
|
Ni, S., Li, Y., Huang, S., Luo, W., Li, C. and Li, X. (2012) Perindopril and losartan attenuate intrahepatic toll-like receptor 4 protein expression in rats with bile duct ligation-induced hepatic fibrosis. Nan Fang Yi Ke Da Xue Xue Bao, 32, 211-214.
|
[46]
|
Siqueira, O.H., Herani, F.B., de Paula, R.E., Ascoli, F.O., da Nóbrega, A.C., Carvalho A.C., et. al. (2013) Tamoxifen decreases the myofibroblast count in the healing bile duct tissue of pigs. Clinics, 68, 101-106.
doi:10.6061/clinics/2013(01)OA16
|
[47]
|
He, H., Mennone, A., Boyer, J.L. and Cai, S.Y. (2011) Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells. Hepatology, 53, 548-557.
doi:10.1002/hep.24047
|
[48]
|
Mas, N., Tasci, I., Comert, B., Ocal, R. and Mas, M.R. (2008) Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis. World Journal of Gastroenterology, 14, 1108-1111.
doi:10.3748/wjg.14.1108
|
[49]
|
Chen, Y.H., Lan, T., Li, J., Qiu, C.H., Wu, T., Gou, H.J. and Lu, M.Q. (2012) Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells. World Journal of Gastroenterology, 18, 7158-7265.
doi:10.3748/wjg.v18.i48.7158
|
[50]
|
Ostapowicz, G., Fontana, R.J., Schiodt, F.V., Larson, A., Davern, T.J., Han, S.H., et al. (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Annals of Internal Medicine, 137, 947-954.
doi:10.7326/0003-4819-137-12-200212170-00007
|
[51]
|
Lee, W.M. (2012) Recent developments in acute liver failure. Best Practice & Research Clinical Gastroenterology, 26, 3-16. doi:10.1016/j.bpg.2012.01.014
|
[52]
|
Services USDoHaH (2005) Annual report of the US organ procurement and transplantation network and the scientific registry of transplant recipients: Transplant data 1995-2004. Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville.
|